Filing Details
- Accession Number:
- 0001567619-21-018626
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-10-22 21:35:03
- Reporting Period:
- 2021-10-20
- Accepted Time:
- 2021-10-22 21:35:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1630627 | Treace Medical Concepts Inc. | TMCI | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1188309 | E Thomas Timbie | C/O Treace Medical Concepts, Inc. 203 Fort Wade Road, Suite 150 Ponte Vedra FL 32081 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-09-07 | 280,000 | $0.00 | 2,540,240 | No | 4 | G | Indirect | Thomas E. Timbie and Pamela F. Timbie, TTEEs of the Thomas E. Timbie Rev Trust u/a dtd May 2, 2001 |
| Common Stock | Disposition | 2021-09-07 | 280,000 | $0.00 | 2,260,240 | No | 4 | G | Indirect | Thomas E. Timbie and Pamela F. Timbie, TTEEs of the Thomas E. Timbie Rev Trust u/a dtd May 2, 2001 |
| Common Stock | Disposition | 2021-10-20 | 11,171 | $25.18 | 2,249,069 | No | 4 | S | Indirect | Thomas E. Timbie and Pamela F. Timbie, TTEEs of the Thomas E. Timbie Rev Trust u/a dtd May 2, 2001 |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | G | Indirect | Thomas E. Timbie and Pamela F. Timbie, TTEEs of the Thomas E. Timbie Rev Trust u/a dtd May 2, 2001 |
| No | 4 | G | Indirect | Thomas E. Timbie and Pamela F. Timbie, TTEEs of the Thomas E. Timbie Rev Trust u/a dtd May 2, 2001 |
| No | 4 | S | Indirect | Thomas E. Timbie and Pamela F. Timbie, TTEEs of the Thomas E. Timbie Rev Trust u/a dtd May 2, 2001 |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- Gifted to irrevocable trust with a third party trustee for the benefit of a natural person.
- Gifted to irrevocable trust with a third party trustee for the benefit of a different natural person.
- The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25 to $25.54 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
